证券代码：300416 证券简称：苏试试验 编号：2024-004 特定对象调研 分析师会议 媒体采访 业绩说明会 投资者关系活 新闻发布会 路演活动 动类别 现场参观 其他 （电话会议） 国泰君安，天风证券，民生证券，东吴证券，光大证券，信达 证券，中信建投，华创证券，国信证券，浙商证券，广发证券， 投资者单位名 兴业证券，国联安基金，博时基金，创金合信基金，惠升基金， 称及人员姓名 银河基金，国联基金，长安基金，富国基金，泰康基金，中欧 基金，嘉实基金等 153 家机构共计 203 位电话会议参会人员。 时间 2024 年 8 月 23 日（星期五）9:00-10:30 地点 电话会议 董事长 钟琼华 董事 陈 英 上市公司 副总经理兼董事会秘书 骆星烁 接待人员姓名 投资者关系总监 向雪莹 一、公司 2024 年半年度业绩情况介绍 投资者关系活 A：公司主营业务收入 91,669.57 万元，同比下降 5.58%，归属 动主要内容介 绍 于上市公司股东的净利润 10,271.68 万元，同比下降 24.35%， 苏州苏试试验集团股份有限公司 投资者关系活动记录表 1 归属于上市公司股东扣除非经常性损益后 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company with a target price of 14.96 CNY, compared to the current price of 11.22 CNY [1]. Core Views - The company's revenue for H1 2024 was 917 million CNY, a decrease of 5.58% year-on-year, while the net profit attributable to shareholders was 103 million CNY, down 24.35% year-on-year. The adjusted net profit was 95 million CNY, reflecting a decline of 26.8% year-on-year [1]. - The second quarter performance was under pressure, but there is optimism for recovery in the future. The company is expected to benefit from ongoing investments in R&D and service capabilities, particularly in high-end manufacturing sectors [1]. - The report highlights a slight increase in gross margin to 45.04% and a slight decrease in net margin to 13.24% for H1 2024 [1]. Financial Summary - For H1 2024, the company reported revenues of 917 million CNY, with a gross margin of 45.04% and a net margin of 13.24% [1]. - The revenue breakdown shows that testing equipment revenue decreased by 14.57% to 291 million CNY, while integrated circuit verification and analysis services grew by 18.22% to 128 million CNY [1]. - The company expects revenues for 2024-2026 to be 2,231 million CNY, 2,702 million CNY, and 3,226 million CNY respectively, with year-on-year growth rates of 5.4%, 21.1%, and 19.4% [2]. Investment Recommendations - The report suggests that despite the current challenges, the long-term growth potential of the company remains strong due to its technological barriers and ongoing expansion in high-end manufacturing applications [1]. - The projected net profits for 2024-2026 are 331 million CNY, 452 million CNY, and 568 million CNY, with growth rates of 5.2%, 36.6%, and 25.7% respectively [2].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook based on its stable operational capabilities as a leader in the testing equipment industry [2][4]. Core Insights - The macroeconomic environment in 2024 is expected to remain relatively weak, with overall downstream demand decreasing. However, special industry orders are anticipated to gradually recover, and the subsidiary Yite's capacity enhancement plan is expected to normalize [2][6]. - The company reported a slight decline in performance for H1 2024, with revenue of 917 million yuan, down 5.58% year-on-year, and a net profit attributable to shareholders of 103 million yuan, down 24.35% year-on-year [6][4]. - The integrated circuit testing segment showed growth, while environmental testing services and equipment faced pressure. Revenue from environmental testing services, testing equipment, and integrated circuit testing was 461 million, 291 million, and 128 million yuan respectively, with year-on-year changes of -1.72%, -14.57%, and +18.22% [6][4]. - The company's gross margin remained stable at 45.04%, while the net margin slightly decreased to 13.24%. The gross margins for environmental testing services, testing equipment, and integrated circuit testing were 55.74%, 31.21%, and 42.87% respectively [6][4]. - The company is focusing on new product and technology development, with ongoing research in various fields including new energy, aerospace, and medical devices. Despite the current macroeconomic challenges, the company is viewed positively for its future business development [6][4]. Financial Projections - Revenue projections for 2024, 2025, and 2026 are estimated at 2.516 billion, 3.014 billion, and 3.616 billion yuan respectively, with a compound annual growth rate (CAGR) of 24.03%. Net profit projections for the same years are 383 million, 492 million, and 600 million yuan [2][6]. - Earnings per share (EPS) are projected to be 0.75, 0.97, and 1.18 yuan per share for 2024, 2025, and 2026 respectively [2][6]. - The company’s financial metrics indicate a stable operating environment, with a projected price-to-earnings (P/E) ratio decreasing from 21.1 in 2022 to 9.5 by 2026, and a price-to-book (P/B) ratio decreasing from 2.6 to 1.6 over the same period [7][6].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company's H1 2024 performance was slightly below expectations due to fluctuations in downstream industry demand, with revenue of 920 million yuan, a year-on-year decrease of 5.6%, and a net profit of 100 million yuan, down 24.4% year-on-year [1] - The integrated circuit verification and analysis business segment saw revenue growth of 18.2% year-on-year, reaching 130 million yuan, contributing 14.0% to total revenue with a gross margin increase of 5.34 percentage points to 42.9% [1] - The company is expected to benefit from capacity expansion in its laboratories and the recovery of downstream demand, leading to improved profitability in the medium to long term [2] Summary by Sections Financial Performance - In Q2 2024, the company achieved revenue of 470 million yuan, a year-on-year decrease of 11.0%, but a quarter-on-quarter increase of 7.2%, with a net profit of 60 million yuan, down 33.8% year-on-year but up 43.6% quarter-on-quarter [1] - The overall gross margin for H1 2024 was 45.0%, an increase of 0.35 percentage points year-on-year, while the net margin was 13.2%, a decrease of 2.91 percentage points year-on-year [1] - The company’s operating costs increased due to rapid capacity expansion, leading to a rise in the expense ratio, which impacted net profit margins [1] Business Segments - The experimental equipment segment faced pressure due to weakened capital expenditure from downstream clients, resulting in a revenue decline of 14.6% year-on-year to 290 million yuan, with a gross margin decrease of 1.31 percentage points to 31.2% [1] - The environmental testing service segment generated revenue of 460 million yuan, a slight decrease of 1.7% year-on-year, with a gross margin decline of 2.23 percentage points to 55.7% [1] - The company’s research and testing institutions segment performed well, achieving revenue of 210 million yuan, up 10.8% year-on-year, with a gross margin increase of 0.73 percentage points to 48.2% [1] Future Outlook - The company is projected to achieve net profits of 350 million yuan, 460 million yuan, and 570 million yuan for 2024, 2025, and 2026 respectively, indicating a compound annual growth rate of 22% over the next three years [2] - The expansion of testing capabilities and the recovery of demand in various sectors, including automotive and aerospace, are expected to drive future growth [2]

东吴证券股份有限公司关于 苏州苏试试验集团股份有限公司 2024 年上半年度跟踪报告 | 保荐机构名称：东吴证券股份有限公司 | 被保荐公司简称：苏试试验 | | --- | --- | | 保荐代表人姓名：程蒙 | 联系电话：0512-62938558 | | 保荐代表人姓名：孙荣泽 | 联系电话：0512-62938558 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1、公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 不适用 | | 2、督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包 | | | 括但不限于防止关联方占用公司资源的制 | 是 | | 度、募集资金管理制度、内控制度、内部审 | | | 计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3、募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 每月查询一次 | | （2）公司募集资金项目进展是否与信息披 | 是 | | 露文件一致 ...

证券代码：300416 证券简称：苏试试验 公告编号：2024-032 苏州苏试试验集团股份有限公司（以下简称"公司"）、控股子公司南京苏试 广博环境可靠性实验室有限公司（以下简称"南京广博"）、湖南苏试广博检测技 术有限公司（以下简称"湖南广博"）、西安苏试广博环境可靠性实验室有限公司 （以下简称"西安广博"）、扬州英迈克测控技术有限公司（以下简称"扬州英迈 克"）、苏试宜特（上海）检测技术股份有限公司（以下简称"上海宜特"）、全资 子公司重庆苏试广博环境可靠性技术有限公司（以下简称"重庆广博"）及控股 孙公司苏试宜特（深圳）检测技术有限公司（以下简称"深圳宜特"）近日取得 了国家知识产权局颁发的发明专利证书，具体情况如下： | 序 号 | 专利名称 | 专利权保护期限 | 授权公告日 | 专利号 | 专利类型 | 专利权人 | | --- | --- | --- | --- | --- | --- | --- | | 1 | 振动台水平滑台液压油回油 流量的自动调节系统 | 2018年11月22日 2038年11月21日 | 2024年1月12日 | ZL2018113 96707.3 | 发明专利 | ...

苏州苏试试验集团股份有限公司 2024 年半年度报告全文 苏州苏试试验集团股份有限公司 2024 年半年度报告 2024 年 08 月 1 苏州苏试试验集团股份有限公司 2024 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人钟琼华、主管会计工作负责人钟琼华及会计机构负责人(会计 主管人员)朱丽军声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本年度报告涉及未来计划等前瞻性陈述，不构成公司对投资者的实质承 诺，敬请投资者注意投资风险。 公司主要存在的风险具体请见本报告"第三节 管理层讨论与分析"之 "十、公司面临的风险和应对措施"。敬请广大投资者关注，并注意投资风 险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 2 苏州苏试试验集团股份有限公司 2024 年半年度报告全文 目录 | --- | --- | |--------------------------------|-- ...

单位：人民币万元 | 非经营性资金占用 | 资金占用方名称 | 占用方与上市公 | 上市公司核算的 | 2024年期初占用资 | 2024年1-6月占用累计发生金额 | | 2024年1-6月占用资金的利息 | 2024年1-6月偿还 | 2024年6月期末 | | 占用形成原因 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 司的关联关系 | 会计科目 | 金余额 | （不含利息） | | （如有） | 累计发生金额 | 占用资金余额 | | | | | 控股股东、实际控制人及 其附属企业 | - | - | - | - | | - | | - | - | - | | | | 小 计 | - | - | - | - | | - | | - | - | - | | | | 前控股股东、实际控制人 及其附属企业 | - | - | - | - | | - | | - | - | - | | | | 小 计 | | | | | | | | | | | | | | | - | ...

东吴证券股份有限公司 （3）查阅公司内部控制评价报告等资料； 1 | （4）查阅募集资金专户的银行对账单等。 | | --- | | 是 1.是否按照相关规定建立内部审计制度并设立内部审计部门 | | 2.是否在股票上市后 6 个月内建立内部审计制度并设立内部 不适用 | | 审计部门 | | 是 3.内部审计部门和审计委员会的人员构成是否合规 | | 4.审计委员会是否至少每季度召开一次会议，审议内部审计 是 | | 部门提交的工作计划和报告等 | | 5.审计委员会是否至少每季度向董事会报告一次内部审计工 是 | | 作进度、质量及发现的重大问题等 | | 6.内部审计部门是否至少每季度向审计委员会报告一次内部 是 | | 审计工作计划的执行情况以及内部审计工作中发现的问题等 | | 7.内部审计部门是否至少每季度对募集资金的存放与使用情 是 | | 况进行一次审计 | | 8.内部审计部门是否在每个会计年度结束前二个月内向审计 是 | | 委员会提交次一年度内部审计工作计划 | | 9.内部审计部门是否在每个会计年度结束后二个月内向审计 是 | | 委员会提交年度内部审计工作报告 | | 10.内部审计 ...

证券代码：300416 证券简称：苏试试验 公告编号：2024-030 苏州苏试试验集团股份有限公司 第五届监事会第五次会议决议公告 监事会经核查认为：公司严格按照《公司法》、《证券法》、《上市公司监管指 引第 2 号-上市公司募集资金管理和使用的监管要求》、《深圳证券交易所上市公 司自律监管指引第 2 号——创业板上市公司规范运作》等有关规定的要求对募集 资金进行使用和管理，募集资金的使用符合募投项目的综合需要，不存在违规使 用募集资金的行为和损害股东利益的情况，符合中国证监会、深圳证券交易所创 业板关于募集资金使用的相关规定。 此议案经与会监事审议，表决结果：3 票同意，0 票反对，0 票弃权。 特此公告。 会议审议并通过如下决议： 一、审议通过《关于公司<2024 年半年度报告>全文及摘要的议案》 监事会经核查认为：董事会编制和审核公司《2024 年半年度报告》的程序 符合法律、行政法规和中国证监会的规定，报告内容真实、准确、完整地反映了 公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。公司《2024 年半年度报告》全文及摘要的具体内容详见公司信息披露网站巨潮资讯网 （http://www. ...